Patients With Mouse Tyrp2 DNA: A Phase I Trial to Assess Safety and Immune Response
Clinical trial NCT00680589 · COMPLETED
Trial details
- NCT number
- NCT00680589
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2011-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.